DSTU2

This page is part of the FHIR Specification (v1.0.2: DSTU 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Medicationorderexample9

This is the narrative for the resource. See also the XML or JSON format.

AC followed by Paclitaxel + Trastuzumab Course 1

Name: Cyclophosphamide in AC (Doxorubicin + Cyclophosphamide)

Course: 1

Agent Protocols Options:

Cyclophosphamide 600 mg/m^2 IV over 30 minutes D1

Offset: None

Cycle length: Q21D x 4 cycles

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.